We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPUH.WS
1951
CALL
DELISTED
Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CPUH.WS
$1.26M ﹤0.01%
125,233
CLAA.WS
1952
CALL
DELISTED
Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CLAA.WS
$1.26M ﹤0.01%
125,344
ROSE
1953
DELISTED
Rose Hill Acquisition Corporation Class A Ordinary Shares
ROSE
$1.26M ﹤0.01%
120,629
-196,983
-62% -$2.02M
RVTY icon
1954
Revvity
RVTY
$12.4B
$1.26M ﹤0.01%
8,996
-3,104
-26% -$418K
CIO
1955
DELISTED
City Office REIT
CIO
$1.26M ﹤0.01%
150,499
-66,245
-31% -$637K
EOCW.WS
1956
CALL
DELISTED
Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EOCW.WS
$1.26M ﹤0.01%
124,995
CAKE icon
1957
Cheesecake Factory
CAKE
$4.91B
$1.26M ﹤0.01%
+39,600
New +$1.32M
FNKO icon
1958
Funko
FNKO
$341M
$1.25M ﹤0.01%
+114,992
New +$1.61M
XLRE icon
1959
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.7B
$1.25M ﹤0.01%
+33,962
New +$1.25M
ESEA icon
1960
Euroseas
ESEA
$535M
$1.25M ﹤0.01%
83,491
+3,215
+4% +$51.8K
SHUA
1961
DELISTED
SHUAA Partners Acquisition Corp I Class A Ordinary Share
SHUA
$1.24M ﹤0.01%
120,504
WKHS icon
1962
Workhorse Group
WKHS
$34M
$1.24M ﹤0.01%
+272
New +$1.87M
EQRXW
1963
CALL
DELISTED
EQRx, Inc. Warrant
EQRXW
$1.24M ﹤0.01%
502,947
AIZ icon
1964
Assurant
AIZ
$14B
$1.23M ﹤0.01%
+9,832
New +$1.31M
APXI
1965
DELISTED
APx Acquisition Corp. I Class A Ordinary Share
APXI
$1.23M ﹤0.01%
119,600
SVFB
1966
DELISTED
SVF Investment Corp. 2 Class A Ordinary Shares
SVFB
$1.23M ﹤0.01%
121,610
SCHL icon
1967
Scholastic
SCHL
$773M
$1.23M ﹤0.01%
+31,063
New +$1.15M
VCXB.WS
1968
CALL
DELISTED
10X Capital Venture Acquisition Corp III Warrants
VCXB.WS
$1.22M ﹤0.01%
124,999
SOAR.WS
1969
CALL
DELISTED
Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SOAR.WS
$1.22M ﹤0.01%
118,929
PAC icon
1970
Grupo Aeroportuario del Pacifico
PAC
$13B
$1.22M ﹤0.01%
8,473
-51
-0.6% -$7.8K
JUGGW
1971
CALL
DELISTED
Jaws Juggernaut Acquisition Corporation Warrant
JUGGW
$1.22M ﹤0.01%
121,124
WPCA.WS
1972
CALL
DELISTED
Warburg Pincus Capital Corporation I-A Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WPCA.WS
$1.22M ﹤0.01%
120,420
DTIL icon
1973
Precision BioSciences
DTIL
$175M
$1.21M ﹤0.01%
33,956
-45,452
-57% -$1.8M
CPARW
1974
CALL
DELISTED
Catalyst Partners Acquisition Corp. Warrant
CPARW
$1.21M ﹤0.01%
119,995
AXAC
1975
DELISTED
AXIOS Sustainable Growth Acquisition Corporation
AXAC
$1.21M ﹤0.01%
117,129

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.